Vaccination of adults with Wistar RA 27/3 rubella vaccine

Abstract

Thirty-three adults were vaccinated subcutaneously with Wistar RA. 27/3 (live attenuated) rubella vaccine at the Wellcome Research Laboratories, Beckenham. All subjects with pre-vaccination haemagglutinating-inhibiting antibody titres of 1/20 or less and three of seven subjects with pre-vaccination titres of 1/40 showed at least fourfold rises of titre. Reactions encountered were mild and of short duration. © 1971, Cambridge University Press. All rights reserved.